Serglycin: at the crossroad of inflammation and malignancy. - Test2 - elhamkhani - TriplyDB

Serglycin: at the crossroad of inflammation and malignancy.

Serglycin: at the crossroad of inflammation and malignancy.

http://www.wikidata.org/entity/Q37467048

about

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans Proteoglycans in liver cancer Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse Insights into the key roles of proteoglycans in breast cancer biology and translational medicine Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma Elevated urinary urea by high-protein diet could be one of the inducements of bladder disorders Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing.Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.The role of heparins and nano-heparins as therapeutic tool in breast cancer.Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.Shed proteoglycans in tumor stroma.Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.Impaired response of the bronchial epithelium to inflammation characterizes severe equine asthma.Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon.Expression of serglycin in human disc is increased in degenerated discs and up-regulated in vitro by exposure to IL-1ß or TNF-α.Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.

P2860

Q21710680-0656A010-9D7B-4429-B3AC-F2B9919EF524 Q26772304-B1BD3579-7D44-4648-923A-364204481F37 Q27329598-EF2CDA1B-8515-436C-B14C-BA05E158B280 Q28085548-93FD8DCA-4F7F-4484-8CB4-02A6ECC53BEF Q28552442-72610ED8-F714-4F92-9DE8-B82D23523C17 Q28573682-7C7725D7-1B2B-4208-924A-AF4D8742E720 Q35813723-4EDE8614-8A83-459F-81F3-688DF7A318AD Q36036383-428D8F91-EAE5-4C62-BD3E-8A79FFAF1DF5 Q37282934-B1A57AC6-700E-4B78-991C-11909711437E Q37725457-F8171B5A-F4ED-493B-A612-56BB15822B4B Q38616484-120E1602-7FF8-45AF-80A7-0EA301F0E1B4 Q38690536-A6338B7D-C911-4B58-B0A0-908BD67BC8F8 Q38806104-5B6178FF-6ED1-47AE-BB7A-E8F1247B29AB Q38822694-2CDE2754-745E-41F9-B43E-8848A4C40B69 Q38882752-C0FEB643-F7DA-45B5-99B9-5EF91E9824B7 Q39411671-1F8EAAE8-EC24-4B2E-AC6C-EB096285A947 Q40060038-71B10AFF-7D28-4540-9A43-842D58F6C5E6 Q42178728-91D890DD-4B66-47C8-9119-2D58101A16B3 Q47281580-044616F2-AE99-45D9-9AE0-0F311ECB880A Q48010288-402D11DD-FD04-4E63-9865-7162F2AE050B Q50106742-75CCDBDE-3EB3-44CB-8DA8-73DD42ACB829 Q54949772-1DFB8725-945F-4142-97E9-A4DC253F1E74 Q55436772-0E9F1E64-2754-4CA0-AC86-0A4979838AEA

P2860

Serglycin: at the crossroad of inflammation and malignancy.

http://www.wikidata.org/entity/Q37467048

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serglycin: at the crossroad of inflammation and malignancy.

@en

Serglycin: at the crossroad of inflammation and malignancy.

@nl

type

label

Serglycin: at the crossroad of inflammation and malignancy.

@en

Serglycin: at the crossroad of inflammation and malignancy.

@nl

prefLabel

Serglycin: at the crossroad of inflammation and malignancy.

@en

Serglycin: at the crossroad of inflammation and malignancy.

@nl

P1433

Q37467048-53419623-82B6-4278-B873-46481CEE2DE4

P1476

Q37467048-171BA862-6AB8-4560-BC42-70D68090213C

P2093

Q37467048-083D3D50-C966-4FA2-AE66-DD2A4744341C

Q37467048-24CB99C6-4F58-4BE0-9D50-21E8AC176AD7

Q37467048-377537C9-0915-408D-A2D3-ADE369FDDE1E

Q37467048-AC14E19E-103B-40E0-AD0D-F9F8F116C9EE

Q37467048-F3202F2B-ACBD-44E8-A3AF-CA2865B9AB05

Q37467048-F531264B-D04C-48E9-89F4-B21103A276B9

P2860

Q37467048-03EC3648-2870-4BF0-B6E0-CAAC1DDDAD84

Q37467048-03FCDA24-7877-43BC-A86E-C14FC025DF61

Q37467048-04AC1ECF-FD29-45E6-B722-5ECB4A36DFD1

Q37467048-06DE0DE0-E3D3-44CF-8488-D7885D749482

Q37467048-086503A6-BB31-46D8-ABEF-2A62FF980A5B

Q37467048-0AB92D11-F10A-4E31-AD72-AB602207C0E5

Q37467048-0ADD0B6B-9D0A-4406-A35F-E404C42D89D5

Q37467048-0C04D589-580D-43F9-9F7C-4BF27317C0F8

Q37467048-0EFE3FC7-AD15-4130-9653-597F6339498E

Q37467048-13AE08F4-0B71-4083-94AA-7B5CF444195D

P304

Q37467048-F44927A1-1EC2-4A15-BD76-00275BC4C3E2

P31

Q37467048-BAB904AF-6AE1-4E75-B446-FE2F66EA23BD

P356

Q37467048-13079731-9F89-4300-9F03-2EF8DA5FEFE2

P478

Q37467048-002CBD69-EB2D-4331-BCA5-54CC8B132941

P50

Q37467048-88DBAA9D-A999-4921-9BEF-69B513BA6E75

P577

Q37467048-50D93E3A-C1EA-4301-9AE1-3AEDE6A7AC8A

P5875

Q37467048-DF9BBA08-EAD4-42D3-AA74-7749CB972490

P698

Q37467048-237BB156-4391-4941-86B4-F30C8D0972E3

P921

Q37467048-F8C2D44D-F246-4E22-BF36-6B626E8F97BC

P932

Q37467048-E6C7B0A6-99E0-4F8B-8B7E-9A8BC824413C

P356

FONC.2013.00327

P1433

Frontiers in Oncology

P1476

Serglycin: at the crossroad of inflammation and malignancy.

@en

P2093

Achilleas D Theocharis

http://www.w3.org/2001/XMLSchema#string

Angeliki Korpetinou

http://www.w3.org/2001/XMLSchema#string

Argyrios Noulas

http://www.w3.org/2001/XMLSchema#string

Gianna Smirlaki

http://www.w3.org/2001/XMLSchema#string

Spyros S Skandalis

http://www.w3.org/2001/XMLSchema#string

Vassiliki T Labropoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Towards a proteome-scale map of the human protein–protein interaction network

Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells

Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation

Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro

Ubiquitin-independent proteasomal degradation of endoplasmic reticulum-localized connexin43 mediated by CIP75

DDA3 recruits microtubule depolymerase Kif2a to spindle poles and controls spindle dynamics and mitotic chromosome movement

Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery

A directed protein interaction network for investigating intracellular signal transduction

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration

In vitro reconstitution of complexes between pro-matrix metalloproteinase-9 and the proteoglycans serglycin and versican

P304

327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2013.00327

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Nikos K. Karamanos

P577

2014-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259880206

http://www.w3.org/2001/XMLSchema#string

P698

24455486

http://www.w3.org/2001/XMLSchema#string

P921

P932

3888995

http://www.w3.org/2001/XMLSchema#string